Retatrutide
Retatrutide
The batch you'll receive
Batch: B-2026-RETA-60-002
Lab: Testides
Purity: >99.94%
Test date: 16.07.2026
View this batch's certificate of analysisAbout
Retatrutide stands out among weight-loss research peptides for acting on three targets at once — the GIP, GLP-1 and glucagon receptors — where most comparable compounds engage only one or two. This triple-receptor activity is what researchers are examining in preclinical models in connection with body-weight regulation, energy expenditure and glycaemic control.
Supplied as a lyophilized powder. Every batch is HPLC-tested to support reproducible results at the bench.
The full scientific detail — mechanism of action, structural characteristics and primary-source references — is available in the linked wiki monograph.
Store the lyophilate dry and protected from light; a freezer is recommended for long-term storage.
Specifications
Q&A
What is the half-life of Retatrutide?
The half-life of retatrutide is approximately 6 days by subcutaneous administration, from the phase 1b study (Lancet). Retatrutide is investigational — no approved FDA/EMA label exists, so the half-life is known from clinical publications rather than a regulatory document. See the Dosing section for detail.
DosingDosing
Human studies evaluated several weekly target doses; no universal escalation schedule has been established.
Full dosing guideTitration schedule · reference
